GlassScriptPhysician profile
Deborah I Cohen
NPI 1811047871
$4,401.11
in general payments reported to CMS, 2019-2025
49 companies · $546 in 2025
The $546 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $276 · 2021: $824 · 2022: $834 · 2023: $827 · 2024: $652 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.58 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $373.56 | 2022-2025 | Veozah |
| Hologic Sales and Service, LLC | $251.17 | 2019-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $247.42 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $228.60 | 2021-2025 | |
| Sage Therapeutics, LLC | $209.14 | 2021-2025 | Zurzuvae |
| Coopersurgical, INC. | $186.74 | 2019-2025 | Paragard T 380a, Mara Console, Ally II Ups |
| Organon LLC | $165.06 | 2022-2025 | Nexplanon, Jada System |
| Amgen INC. | $149.27 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $143.85 | 2021-2024 | |
| Millicent US INC | $135.50 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Therapeuticsmd, INC. | $134.49 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.57 | 2019-2025 | |
| Myriad Women'S Health, INC. | $115.30 | 2023 | Myrisk |
| Evofem Biosciences, INC. | $108.44 | 2020-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $104.48 | 2019 | |
| Sumitomo Pharma America, INC. | $97.65 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $73.05 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $64.44 | 2020-2022 | |
| Lupin INC. | $63.98 | 2020-2021 | |
| Baxter Healthcare | $59.46 | 2023 | Tisseel |
| Radius Health, INC. | $59.26 | 2022-2023 | Tymlos |
| Exeltis, USA INC. | $54.08 | 2020-2025 | Slynd |
| Vertical Pharmaceuticals, LLC | $53.14 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $51.87 | 2021 | |
| Dysis Medical, INC. | $44.71 | 2020 | |
| Meditrina | $44.31 | 2023-2025 | |
| Optumhealth Care Solutions, LLC | $37.66 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Channel Medsystems, INC. | $37.45 | 2023-2025 | |
| Boston Scientific Corporation | $34.05 | 2021-2023 | |
| Exact Sciences Corporation | $34.01 | 2023-2025 | Cologuard Collection Kit |
| Ascend Therapeutics US, LLC | $32.82 | 2022-2024 | |
| Covidien LP | $29.05 | 2019 | |
| Avion Pharmaceuticals | $28.22 | 2019-2023 | Balcoltra |
| Supernus Pharmaceuticals, INC. | $27.68 | 2025 | Qelbree |
| Agile Therapeutics, INC. | $25.81 | 2021-2022 | |
| Monaghan Medical Corporation | $25.08 | 2024 | Aerobika |
| Neuronetics, INC. | $24.63 | 2024 | Neurostar Tms Therapy System |
| Duchesnay USA Incorporated | $24.39 | 2019 | |
| Novo Nordisk INC | $22.75 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $19.22 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $18.60 | 2023 | Vivjoa |
| Northgate Technologies, INC. | $18.46 | 2024 | Stimsite |
| Aspira Women'S Health INC | $17.77 | 2021 | |
| Qiagen, LLC | $17.24 | 2023 | Quantiferon-Tb Gold Plus |
| Coloplast Corp | $15.70 | 2021 | |
| Shield Therapeutics INC | $14.33 | 2023 | Accrufer |
| Medicem INC. | $12.94 | 2021 | |
| Allergan, INC. | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.